The medical device company reported strong full year 2025 results, with revenues and EBITDA both increasing significantly. The integration of a recent acquisition is progressing well, supporting the company's growth trajectory.
The healthcare company has announced changes to its major shareholder holdings.
The healthcare company has announced a change in major shareholding, with Richard Griffiths and his controlled holdings now owning 4.18% of the company's shares.
The medical device company announces it will be participating in investor conferences in November and December.
The healthcare company has released a regulatory notification regarding a change in shareholding.
The healthcare company has released a regulatory announcement, but the details do not indicate any significant changes to the business.
The healthcare company has announced a director's personal share transactions as part of tax planning.
The healthcare company announces a director's share transactions as part of normal tax planning.
The healthcare company has disclosed a change in major shareholding, with Briarwood Chase Management LLC now holding over 5% of the voting rights.
The medical technology firm reported strong H1 growth, with revenue up 63% and adjusted profit before tax rising 11%. Integration of recent acquisitions is progressing well, supporting future growth prospects.